CLINICAL_TRIALS
trial_result
· 2019-07-05
Clinical Trial Update: A First-in-human Study Evaluating Romosozumab (AMG 785) in Healthy Men and Postmenopausal Women [Phase 1]
Summary
First-in-human Phase 1 trial of romosozumab (AMG 785) in healthy men and postmenopausal women with osteopenia; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteopenia | Phase 1 | Status: COMPLETED | Results posted: 2019-07-05